Prediction of the clinical course of COPD using the old and the new GOLD classification Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005
Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011
GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003
Validation of the GOLD 2017 classification in a Chinese COPD cohort Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012
Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012
Stage 0 in GOLD does not predict future clinical COPD Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002
Distribution of a COPD population based on the GOLD assessment framework Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012
Relationship between quality of life and severity of COPD according to GOLD classification Source: Eur Respir J 2004; 24: Suppl. 48, 15s Year: 2004
Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II Source: Eur Respir J 2005; 26: Suppl. 49, 434s Year: 2005
Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria Source: Eur Respir J 2002; 20: Suppl. 38, 251s Year: 2002
Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002
Combined COPD assessment using the new GOLD guidelines Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012
Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
The prevalence of QTc-prolongation increase by GOLD stage in COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017
Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003